It’s been a wild four months for the Boulder-based biopharmaceutical maker formerly known as Miragen.

Now known as Viridian Therapeutics Inc. (Nasdaq: VRDN), the company this week completed a rebrand to cap off four months of tumult for the company, which was kicked off by the resignation of co-founder Bill Marshall several months ago.

At the time, the legacy Miragen said it would seek a strategic alternative. That phrase is a signal that a company is looking to be acquired or merge with…

… Continue Reading at: [source]